FDA approves first drug in U.S. with digital ingestion tracking
IN -

(Reuters) - The U.S. Food and Drug Administration said on Monday that it had approved Otsuka Pharmaceutical Co Ltd's Abilify MyCite, the first drug with a digital ingestion tracking system to be approved in the United States.

Loading...

Related Articles